Data as of Apr 17
| -0.26 / -1.04%|
The 5 analysts offering 12-month price forecasts for Hyperion Therapeutics Inc have a median target of 39.00, with a high estimate of 40.00 and a low estimate of 35.00. The median estimate represents a +57.70% increase from the last price of 24.73.
The current consensus among 5 polled investment analysts is to Buy stock in Hyperion Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.